Patent US9639150 message

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+) Patent US9639150 message

Filing Names

Zealand Pharma A s
Zealand Pharma A s And Wyeth

Zealand Pharma A s patents

Recent patent applications related to Zealand Pharma A s. Zealand Pharma A s is listed as an Agent/Assignee. Note: Zealand Pharma A s may have other listings under different names/spellings. We're not affiliated with Zealand Pharma A s, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "Z" | Zealand Pharma A s-related inventors

Date Zealand Pharma A s patents (updated weekly) - BOOKMARK this page
05/18/17Glucagon-like-peptide-2 (glp-2) analogues
04/20/17Peptide agonists of glp-1 activity
12/08/16Glucagon-like-peptide-2 (glp-2) analogues
12/01/16Glucagon analogues
10/20/16Glucagon analogues
09/29/16Gip-glp-1 dual agonist compounds and methods
09/22/16Amylin analogues
09/08/16Glucagon-glp-1-gip triple agonist compounds
06/30/16Peptide conjugates of glp-1 receptor agonists and gastrin and their use
05/05/16Acylated glucagon analogues
03/24/16Glp-1 receptor agonist peptide gastrin conjugates
01/14/16Glucagon analogues
01/07/16Combination of acylated glucagon analogues with insulin analogues
12/31/15Glucagon analogues
12/24/15Glucagon-like-peptide-2 (glp-2) analogues
11/12/15Synthesis of pyrrolidine compounds
10/22/15Gip-glp-1 dual agonist compounds and methods
07/30/15Glucagon analogues
05/07/15Glucagon-like-peptide-2 (glp-2) analogues
04/23/15Glucagon analogues
04/23/15Acylated glucagon analogues
03/19/15Glucagon analogues
01/15/15Ghrelin analogues
11/13/14Peptide agonists of glp-1 activity
07/03/14Glp-1 and methods for treating diabetes
03/20/14Glucagon analogues
01/09/14Combination of acylated glucagon analogues with insulin analogues
11/28/13Glucagon analogues
08/29/13Modified lysine-mimetic compounds
08/15/13Methods for using peptide agonists having glp-1 activity
06/20/13Glucagon analogues
06/20/13Glucagon analogues
06/20/13Treatment of cardiac conditions
06/06/13Peptide conjugates of glp-1 receptor agonists and gastrin and their use
02/28/13Synthesis of pyrrolidine compounds
11/15/12Glucagon-like-peptide-2 (glp-2) analogues
09/27/12Modified lysine-mimetic compounds
07/12/12Acylated glucagon analogues
01/05/12Selective glucagon-like-peptide-2 (glp-2) analogues
12/22/11Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/01/11Glucagon analogues
12/01/11Glucagon analogues
11/24/11Glucagon analogues
11/24/11Glucagon analogues
06/23/11Glucagon-like-peptide-2 (glp-2) analogues
04/28/11Glucagon-like-peptide-2 (glp-2) analogues
08/12/10Glucagon analogues
02/25/10Truncated pth peptides with a cyclic conformation
08/20/09Stabilized exendin-4 compounds
04/02/09Glp-1 and methods for treating diabetes
03/19/09Peptide-based regulation of gap junctions
09/30/10Modified lysine-mimetic compounds

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Zealand Pharma A s in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Zealand Pharma A s with additional patents listed. Browse our Agent directory for other possible listings. Page by